Product Pipeline
Find out about the anti-cancer drugs we have in development
Press Releases
-
Astex Pharmaceuticals Presents Overall Survival Data From ASCERTAIN Phase 3 Study of Oral Hypomethylating Agent INQOVI® (decitabine and cedazuridine) in MDS and CMML at International Congress on Myelodysplastic Syndromes
-
Taiho Oncology To Share Data in Advanced Solid Tumors at ESMO Congress 2021
-
Open Letter From Taiho Oncology on Blood Cancer Awareness Month